Electromagnetic navigation bronchoscopy: clinical utility in the diagnosis of lung cancer [0.03%]
电磁导航支气管镜在肺癌诊断中的临床应用价值
Luis M Seijo
Luis M Seijo
Electromagnetic navigation bronchoscopy (ENB) is one of several technological advances which have broadened the indications for bronchoscopy in the diagnostic workup of lung cancer. The technique facilitates bronchoscopic sampling of periph...
Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma [0.03%]
晚期肺鳞癌化疗的疗效及预后因素分析
Seigo Minami,Yoshitaka Ogata,Shouichi Ihara et al.
Seigo Minami et al.
Background: Pulmonary squamous cell carcinoma has not benefited from improvements in chemotherapy over the past decade, compared with non-squamous non-small-cell lung cancer. Nowadays, treatment strategies differ between ...
Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer [0.03%]
瑞戈非尼及其在非小细胞肺癌治疗中的潜力的研究进展
Phu N Tran,Samuel J Klempner
Phu N Tran
Patients with non-small-cell lung cancer (NSCLC) harboring activating mutations in EGFR benefit from treatment with EGFR small-molecule tyrosine-kinase inhibitors. However, the development of acquired resistance to EGFR inhibitors is univer...
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives [0.03%]
克唑替尼治疗ALK阳性的晚期非小细胞肺癌：一线选择与展望
Etienne Giroux-Leprieur,Vincent Fallet,Jacques Cadranel et al.
Etienne Giroux-Leprieur et al.
Around 4% of advanced non-small-cell lung cancers (NSCLCs) have an ALK rearrangement at the time of diagnosis. This molecular feature is more frequent in young patients, with no/light smoking habit and with adenocarcinoma pathological subty...
Fatigue in lung cancer patients: symptom burden and management of challenges [0.03%]
肺癌患者的疲劳感：症状负担与应对挑战
Simona Carnio,Rosario Francesco Di Stefano,Silvia Novello
Simona Carnio
Lung cancer (LC) remains the most common cause of cancer death in several countries across the world. Fatigue is the most frequently reported symptom in LC patients throughout the entire course of disease, and all international guidelines r...
Shivani C Patel,Jonathan E Dowell
Shivani C Patel
Malignant pleural mesothelioma (MPM) is a deadly disease that produces a significant worldwide health care burden. The majority of cases are associated with prior asbestos exposure, but recent studies have identified a possible genetic pred...
High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells [0.03%]
醛酮还原酶1C1高表达与小细胞肺癌增殖和迁移的关系研究
He Tian,Xing Li,Wenli Jiang et al.
He Tian et al.
AKR1C1 is a member of the AKR1C family, which not only plays an important role in hormone metabolism but is believed to be involved in carcinogen metabolism. Our previous study demonstrated that AKR1C1 was highly expressed in lung tumor tis...
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography [0.03%]
根治性治疗后肺癌患者的监测和管理：18F-氟脱氧葡萄糖正电子发射断层显像/计算机体层成像的临床应用价值
Shigeki Sawada,Hiroshi Suehisa,Tsuyoshi Ueno et al.
Shigeki Sawada et al.
A large number of studies have demonstrated that 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography (FDG-PET/CT) is superior to conventional modalities for the diagnosis of lung cancer and the evaluatio...
Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer [0.03%]
小细胞肺癌化疗疗效的回顾性分析及预后因素研究
Seigo Minami,Yoshitaka Ogata,Shouichi Ihara et al.
Seigo Minami et al.
Background: Small-cell lung cancer (SCLC) is responsive to initial chemotherapy but becomes resistant to cytotoxic drugs. The aim of this study was to evaluate what proportion of patients with SCLC had received the first-...
Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer [0.03%]
肺癌患者肺叶切除术后随访的优化策略
Ying-Yi Chen,Tsai-Wang Huang,Hung Chang et al.
Ying-Yi Chen et al.
Introduction: The rationale for oncologic surveillance following pulmonary lobectomy is to detect recurrent disease or a second primary lung cancer early enough so that an intervention can increase survival and/or improve...